Scientists who make the Corona vaccine tell their story for the first time, how they work in the lab

 Scientists who make the Corona vaccine tell their story for the first time, how they work in the lab

 Scientists from 'Bharat Biotech' and 'Biological E', two companies based in Hyderabad's Gnome Valley, shared their experience with Bhaskar

 Most of the scientists who were involved in vaccine development work, worked in two, sometimes three or three shifts.

 The story of those who made the Corona vaccine eagerly waiting for the whole country today.  The story of the scientists who spent their entire research in the lockdown lab.  The story of scientists who, like us, learned in January last year that Corona

  The epidemic is spreading across the world and has no vaccine.  In Corona Warriors shared their experience so far with Bhaskar for the first time.  Read the story of each scientist of two companies based in Hyderabad, 'Bharat Biotech' and 'Biological E'.

 MD asked, how much risk do you know?  Vijay had said on this - what is the risk sir

 This was in April, when team members were being selected for the corona vaccine at Bharat Biotech.  The team that was to be involved in the vaccine work had to work in the Bio Safety Level-3 (BSL-3) lab.  For several months, he had to leave the house and stay in the factory guest house.

 When the company's MD Dr. Krishna Alla asked colleagues who wanted to get involved in vaccine development work, everyone raised their hands.  One of them was Vijay Kumar Darum.  Vijay first agreed to go to the lab.

 Dr. Alla asked him, "You know how much risk it can be," Vijay said, "What is the risk, sir."  I want to do vaccine development. '  When PM Bharat reached Biotech on 28 November, he was also introduced to Vijay by Dr. Krishna.

 A team of 200 people is engaged in developing Bharat Biotech's 'Kovaxin'.  There are 50 people who work inside the lab.  20 of them are scientists.  The team of scientists did not go home from July to November, i.e. five months.  These people were staying in the company's guest house and were engaged in vaccine research and development here day and night.  These people started going home from December.

 We have to work between live viruses in the lab, the wife supported, so I was able to give the entire time in the lab.

 Vijay says, "When me and my colleagues were involved in this project, we felt very happy and proud that we are going to be a part of the project developing the vaccine, which will save lives of millions of people."  .  But, there was also the challenge to develop this vaccine at the earliest.

 'We started work on this project from April.  We did not go home for five months.  Then most of the time was spent in the lab.  Raw material mobilization was also a challenge when the lockdown was underway.  We have a Bio Safety Level-3 (BSL-3) facility lab, which is considered to be very safe and we only have this lab in India.

 He said, "Here we have to handle live virus, because the type of corona vaccine that we are making is prepared by the virus itself.  In this situation, this work has to be done very carefully, because even a single leakage can cause infection.

 We asked Vijay what did you guys do to avoid infection?  In response, he said, 'Apart from PPE, we wear primary gowns, secondary gowns, double gloves.'  On the question that when you were engaged in research and could not go home, then who handled your responsibilities at home?

  He said that the wife took over all my responsibilities.  He saw all the work from home as well as outside.  Due to this, we were able to give so much time in the lab.  However, Scientists have started going home from the first week of December.

 Scientists from 'Bharat Biotech' and 'Biological E', two companies based in Hyderabad's Gnome Valley, shared their experience with Bhaskar

 Most of the scientists who were involved in vaccine development work, worked in two, sometimes three or three shifts.

 The story of those who made the Corona vaccine eagerly waiting for the whole country today.  The story of the scientists who spent their entire research in the lockdown lab.  The story of scientists who, like us, came to know in January last year that

 The corona epidemic is spreading across the world and has no vaccine.  In Corona Warriors shared their experience so far with Bhaskar for the first time.  Read the story of each scientist of two companies based in Hyderabad, 'Bharat Biotech' and 'Biological E'.

 MD asked, how much risk do you know?  Vijay had said on this - what is the risk sir

 This was in April, when team members were being selected for the corona vaccine at Bharat Biotech.  The team that was to be involved in the vaccine work had to work in the Bio Safety Level-3 (BSL-3) lab.  For several months, he had to leave the house and stay in the factory guest house.

 When the company's MD Dr. Krishna Alla asked colleagues who wanted to get involved in vaccine development work, everyone raised their hands.  One of them was Vijay Kumar Darum.  Vijay first agreed to go to the lab.  Dr

 .  Alla asked him, "You know how much risk it can be," Vijay said, "What is the risk, sir."  I want to do vaccine development. '  When PM Bharat reached Biotech on 28 November, he was also introduced to Vijay by Dr. Krishna.

 A team of 200 people is engaged in developing Bharat Biotech's 'Kovaxin'.  There are 50 people who work inside the lab.  20 of them are scientists.  The team of scientists did not go home from July to November, i.e. five months.  these

  People were staying in the company's guest house and were engaged in vaccine research and development here day and night.  These people started going home from December.

 We have to work between live viruses in the lab, the wife supported, so I was able to give the entire time in the lab.

 Vijay says, "When me and my colleagues were involved in this project, we felt very happy and proud that we are going to be a part of the project developing the vaccine, which will save lives of millions of people."  .  But, there was also the challenge to develop this vaccine at the earliest.

 'We started work on this project from April.  We did not go home for five months.  Then most of the time was spent in the lab.  Raw material mobilization was also a challenge when the lockdown was underway.  We have a Bio Safety Level-3 (BSL-3) facility lab, which is considered to be very safe and we only have this lab in India.

 He said, "Here we have to handle live virus, because the type of corona vaccine that we are making is prepared by the virus itself.  In this situation, this work has to be done very carefully, because even a single leakage can cause infection.

 We asked Vijay what did you guys do to avoid infection?  In response, he said, 'Apart from PPE, we wear primary gowns, secondary gowns, double gloves.'  On the question that when you were engaged in research and could not go home, then who handled your responsibilities at home?  He said that the wife took over all my responsibilities.

 He saw all the work from home as well as outside.  Due to this, we were able to give so much time in the lab.  However, Scientists have started going home from the first week of December.

 (2021 is the biggest year of expectations for this century. Reason- The vaccine that protected more than one crore people in the country will start the new year. So, 2021 is the hope on the forehead.  Is a commentary of.)

 Second story of Dr. Vikram Paradkar

 Dr. Paradkar is a Scientist and an Executive Vice President at Biological E Company.  He and his team have been involved in the development of the Corona vaccine for the past nine months.  The story ahead, by Dr. Paradkar's own words ...

 A team of 40 scientists, read literature, the mind does not stop thinking ...

 Dr. Paradkar says, 'There are two thousand employees in our company.  A team of 40 scientists is involved in the development of the Corona vaccine.  Their age is between 25 and 55 years.  We were engaged in vaccine development when everything was closed in lockdown.  We were allowed to travel due to essential services.

 'Used to travel by company bus.  Working hours are usually 40 to 45 hours a week, but now many times 60 to 65 hours are also being done.  Many times, two shifts are completed simultaneously, because the process that is going on, we have to monitor the continuum.

  Literature search has to be done.  With this, the thinking keeps going on in the mind.  Our entire team is experienced.  We have developed many vaccines, so everyone knows how to do their work. '

 The kit changes according to the situation, the proteins were made, so there was no risk of infection.

 Dr. Paradkar said that there are 6 types of categories in the vaccine.  We are making a protein sub-unit category vaccine.  Virus is not required for making vaccines in this category.  Protein is developed in the lab.  It is the safest, because there is no virus in it.

 So we are completely safe in the lab.  Still everyone comes to the factory from home.  Market goes, so protection is necessary.  Where necessary, we wear complete kit for protection.  The lab wears gloves, masks and face shields.  When we go to the manufacturing unit, the entire body is covered.

 They say that our kit is different according to each situation.  Our families know how we work, because we have been doing this work for years.  Even in Corona, they knew that we were making protein so they were not in tension.

 Some scientists fell victim to Corona, some had to change their homes

 He said, 'The biggest challenge before us is to develop an effective and completely safe vaccine.  Some other challenges also came up, such as some companions who were living in sharing.  When the landlord refused them to go out in lockdown, they stayed in the company's guest house.

 There are some companions who took the house near the company at the time of lockdown, so that there would be no problem in movement.  Some Scientists also succumbed to coronavirus.  He was immediately quarantined by the company and got his treatment done.  After recovering, he got ready in the lab again.

 Dr. Paradkar says, 'The most unique thing is that no one has ever refused to do any work, nor said that the shift will be completed.  Team members gave their 100 percent.  As a result, we have come so close to developing a vaccine.  A completely safe and effective vaccine will be ready in a few months.

 So far, 150 volunteers have been vaccinated in the trial, phase three trials will start in February

 They say that our phase one and phase two trials are going on simultaneously.  In these two phases we have to give vaccine to a total of 360 people, out of which 150 people have been given.  Our trials are going on at seven places in the country.  We are testing four types of variants.  Whichever type of safety and immunity will be best, the vaccine will be developed on that type.

 He told, 'By February we will choose one of the four best combinations.  After this, we will start clinical trial of phase three.  Phase Three will include volunteers from 12 to 80 years old so that the vaccine can be prepared for everyone.  This will also include such patients, who are already suffering from serious diseases.  In February – March, we conducted the initial vaccine research and started vaccine development from April.  Our Phase Three clinical trials will begin by April this year.

 It usually takes four years for a vaccine to reach this stage.  However, the corona vaccine reached this stage within a year, as all the resources of the company are engaged on it.  Now all other work has been done backward.  The government's review is also happening frequently.  This is not wasting time in paper work.

 Having been vaccinated for 50 years, our vaccine reaches 120 countries

 Dr. Paradkar said, 'I also want to tell about the beginning of vaccine development.  In January, China announced that a new virus has arrived, named Coronavirus.  WHO then said that this human-to-human is transmitting and there is a possibility of it spreading across the world.

 As soon as the WHO was announced, it was learned that this infection is going to turn into an epidemic.  Everyone was upset because no one had the immunity to avoid it.  Then we thought that there is only one way to avoid this epidemic, and that is the vaccine. '

 'Our company has been making vaccines for the last nearly 50 years.  We sell vaccines in 120 countries.  We have been supplying the vaccine for the government program for fifty years.  So we took the decision that we would make the vaccine.  We first researched which type of vaccine we can make.  We have developed a hepatitis vaccine.

 We have been making this vaccine for the last fifteen years, which is completely safe and effective, so we thought that we will also develop a coronavirus vaccine based on this technology.  The Massachusetts Institute of Technology (MIT) and the Boiler College of Medicine were also planning to conduct vaccine research on the same technology as we thought.

 He explains that MIT and Boiler College prepared the concept and contacted us that if you have the capacity, can we together make this vaccine.  After evaluating everything, it was agreed to make the vaccine together.  Fixed the vaccine candidate in July.  Tested on animals and designed the vaccine.  Then began clinical trials, which are currently underway.

 Scientists who make the Corona vaccine tell their story for the first time, how they work in the lab

 Scientists from 'Bharat Biotech' and 'Biological E', two companies based in Hyderabad's Gnome Valley, shared their experience with Bhaskar

 Most of the scientists who were involved in vaccine development work, worked in two, sometimes three or three shifts.

 The story of those who made the Corona vaccine eagerly waiting for the whole country today.  The story of the scientists who spent their entire research in the lockdown lab.  The story of scientists who, like us, learned in January last year that Corona

  The epidemic is spreading across the world and has no vaccine.  In Corona Warriors shared their experience so far with Bhaskar for the first time.  Read the story of each scientist of two companies based in Hyderabad, 'Bharat Biotech' and 'Biological E'.

 MD asked, how much risk do you know?  Vijay had said on this - what is the risk sir

 This was in April, when team members were being selected for the corona vaccine at Bharat Biotech.  The team that was to be involved in the vaccine work had to work in the Bio Safety Level-3 (BSL-3) lab.  For several months, he had to leave the house and stay in the factory guest house.

 When the company's MD Dr. Krishna Alla asked colleagues who wanted to get involved in vaccine development work, everyone raised their hands.  One of them was Vijay Kumar Darum.  Vijay first agreed to go to the lab.

 Dr. Alla asked him, "You know how much risk it can be," Vijay said, "What is the risk, sir."  I want to do vaccine development. '  When PM Bharat reached Biotech on 28 November, he was also introduced to Vijay by Dr. Krishna.

 A team of 200 people is engaged in developing Bharat Biotech's 'Kovaxin'.  There are 50 people who work inside the lab.  20 of them are scientists.  The team of scientists did not go home from July to November, i.e. five months.  These people were staying in the company's guest house and were engaged in vaccine research and development here day and night.  These people started going home from December.

 We have to work between live viruses in the lab, the wife supported, so I was able to give the entire time in the lab.

 Vijay says, "When me and my colleagues were involved in this project, we felt very happy and proud that we are going to be a part of the project developing the vaccine, which will save lives of millions of people."  .  But, there was also the challenge to develop this vaccine at the earliest.

 'We started work on this project from April.  We did not go home for five months.  Then most of the time was spent in the lab.  Raw material mobilization was also a challenge when the lockdown was underway.  We have a Bio Safety Level-3 (BSL-3) facility lab, which is considered to be very safe and we only have this lab in India.

 He said, "Here we have to handle live virus, because the type of corona vaccine that we are making is prepared by the virus itself.  In this situation, this work has to be done very carefully, because even a single leakage can cause infection.

 We asked Vijay what did you guys do to avoid infection?  In response, he said, 'Apart from PPE, we wear primary gowns, secondary gowns, double gloves.'  On the question that when you were engaged in research and could not go home, then who handled your responsibilities at home?

  He said that the wife took over all my responsibilities.  He saw all the work from home as well as outside.  Due to this, we were able to give so much time in the lab.  However, Scientists have started going home from the first week of December.

 Scientists from 'Bharat Biotech' and 'Biological E', two companies based in Hyderabad's Gnome Valley, shared their experience with Bhaskar

 Most of the scientists who were involved in vaccine development work, worked in two, sometimes three or three shifts.

 The story of those who made the Corona vaccine eagerly waiting for the whole country today.  The story of the scientists who spent their entire research in the lockdown lab.  The story of scientists who, like us, came to know in January last year that

 The corona epidemic is spreading across the world and has no vaccine.  In Corona Warriors shared their experience so far with Bhaskar for the first time.  Read the story of each scientist of two companies based in Hyderabad, 'Bharat Biotech' and 'Biological E'.

 MD asked, how much risk do you know?  Vijay had said on this - what is the risk sir

 This was in April, when team members were being selected for the corona vaccine at Bharat Biotech.  The team that was to be involved in the vaccine work had to work in the Bio Safety Level-3 (BSL-3) lab.  For several months, he had to leave the house and stay in the factory guest house.

 When the company's MD Dr. Krishna Alla asked colleagues who wanted to get involved in vaccine development work, everyone raised their hands.  One of them was Vijay Kumar Darum.  Vijay first agreed to go to the lab.  Dr

 .  Alla asked him, "You know how much risk it can be," Vijay said, "What is the risk, sir."  I want to do vaccine development. '  When PM Bharat reached Biotech on 28 November, he was also introduced to Vijay by Dr. Krishna.

 A team of 200 people is engaged in developing Bharat Biotech's 'Kovaxin'.  There are 50 people who work inside the lab.  20 of them are scientists.  The team of scientists did not go home from July to November, i.e. five months.  these

  People were staying in the company's guest house and were engaged in vaccine research and development here day and night.  These people started going home from December.

 We have to work between live viruses in the lab, the wife supported, so I was able to give the entire time in the lab.

 Vijay says, "When me and my colleagues were involved in this project, we felt very happy and proud that we are going to be a part of the project developing the vaccine, which will save lives of millions of people."  .  But, there was also the challenge to develop this vaccine at the earliest.

 'We started work on this project from April.  We did not go home for five months.  Then most of the time was spent in the lab.  Raw material mobilization was also a challenge when the lockdown was underway.  We have a Bio Safety Level-3 (BSL-3) facility lab, which is considered to be very safe and we only have this lab in India.

 He said, "Here we have to handle live virus, because the type of corona vaccine that we are making is prepared by the virus itself.  In this situation, this work has to be done very carefully, because even a single leakage can cause infection.

 We asked Vijay what did you guys do to avoid infection?  In response, he said, 'Apart from PPE, we wear primary gowns, secondary gowns, double gloves.'  On the question that when you were engaged in research and could not go home, then who handled your responsibilities at home?  He said that the wife took over all my responsibilities.

 He saw all the work from home as well as outside.  Due to this, we were able to give so much time in the lab.  However, Scientists have started going home from the first week of December.

 (2021 is the biggest year of expectations for this century. Reason- The vaccine that protected more than one crore people in the country will start the new year. So, 2021 is the hope on the forehead.  Is a commentary of.)

 Second story of Dr. Vikram Paradkar

 Dr. Paradkar is a Scientist and an Executive Vice President at Biological E Company.  He and his team have been involved in the development of the Corona vaccine for the past nine months.  The story ahead, by Dr. Paradkar's own words ...

 A team of 40 scientists, read literature, the mind does not stop thinking ...

 Dr. Paradkar says, 'There are two thousand employees in our company.  A team of 40 scientists is involved in the development of the Corona vaccine.  Their age is between 25 and 55 years.  We were engaged in vaccine development when everything was closed in lockdown.  We were allowed to travel due to essential services.

 'Used to travel by company bus.  Working hours are usually 40 to 45 hours a week, but now many times 60 to 65 hours are also being done.  Many times, two shifts are completed simultaneously, because the process that is going on, we have to monitor the continuum.

  Literature search has to be done.  With this, the thinking keeps going on in the mind.  Our entire team is experienced.  We have developed many vaccines, so everyone knows how to do their work. '

 The kit changes according to the situation, the proteins were made, so there was no risk of infection.

 Dr. Paradkar said that there are 6 types of categories in the vaccine.  We are making a protein sub-unit category vaccine.  Virus is not required for making vaccines in this category.  Protein is developed in the lab.  It is the safest, because there is no virus in it.

 So we are completely safe in the lab.  Still everyone comes to the factory from home.  Market goes, so protection is necessary.  Where necessary, we wear complete kit for protection.  The lab wears gloves, masks and face shields.  When we go to the manufacturing unit, the entire body is covered.

 They say that our kit is different according to each situation.  Our families know how we work, because we have been doing this work for years.  Even in Corona, they knew that we were making protein so they were not in tension.

 Some scientists fell victim to Corona, some had to change their homes

 He said, 'The biggest challenge before us is to develop an effective and completely safe vaccine.  Some other challenges also came up, such as some companions who were living in sharing.  When the landlord refused them to go out in lockdown, they stayed in the company's guest house.

 There are some companions who took the house near the company at the time of lockdown, so that there would be no problem in movement.  Some Scientists also succumbed to coronavirus.  He was immediately quarantined by the company and got his treatment done.  After recovering, he got ready in the lab again.

 Dr. Paradkar says, 'The most unique thing is that no one has ever refused to do any work, nor said that the shift will be completed.  Team members gave their 100 percent.  As a result, we have come so close to developing a vaccine.  A completely safe and effective vaccine will be ready in a few months.

 So far, 150 volunteers have been vaccinated in the trial, phase three trials will start in February

 They say that our phase one and phase two trials are going on simultaneously.  In these two phases we have to give vaccine to a total of 360 people, out of which 150 people have been given.  Our trials are going on at seven places in the country.  We are testing four types of variants.  Whichever type of safety and immunity will be best, the vaccine will be developed on that type.

 He told, 'By February we will choose one of the four best combinations.  After this, we will start clinical trial of phase three.  Phase Three will include volunteers from 12 to 80 years old so that the vaccine can be prepared for everyone.  This will also include such patients, who are already suffering from serious diseases.  In February – March, we conducted the initial vaccine research and started vaccine development from April.  Our Phase Three clinical trials will begin by April this year.

 It usually takes four years for a vaccine to reach this stage.  However, the corona vaccine reached this stage within a year, as all the resources of the company are engaged on it.  Now all other work has been done backward.  The government's review is also happening frequently.  This is not wasting time in paper work.

 Having been vaccinated for 50 years, our vaccine reaches 120 countries

 Dr. Paradkar said, 'I also want to tell about the beginning of vaccine development.  In January, China announced that a new virus has arrived, named Coronavirus.  WHO then said that this human-to-human is transmitting and there is a possibility of it spreading across the world.

 As soon as the WHO was announced, it was learned that this infection is going to turn into an epidemic.  Everyone was upset because no one had the immunity to avoid it.  Then we thought that there is only one way to avoid this epidemic, and that is the vaccine. '

 'Our company has been making vaccines for the last nearly 50 years.  We sell vaccines in 120 countries.  We have been supplying the vaccine for the government program for fifty years.  So we took the decision that we would make the vaccine.  We first researched which type of vaccine we can make.  We have developed a hepatitis vaccine.

 We have been making this vaccine for the last fifteen years, which is completely safe and effective, so we thought that we will also develop a coronavirus vaccine based on this technology.  The Massachusetts Institute of Technology (MIT) and the Boiler College of Medicine were also planning to conduct vaccine research on the same technology as we thought.

 He explains that MIT and Boiler College prepared the concept and contacted us that if you have the capacity, can we together make this vaccine.  After evaluating everything, it was agreed to make the vaccine together.  Fixed the vaccine candidate in July.  Tested on animals and designed the vaccine.  Then began clinical trials, which are currently underway.